Accession Number: | 0001127602-21-006982 |
Date: | 2021-02-18 |
Issuer: | BIOGEN INC. (BIIB) |
Original Submission Date: |
GUINDO CHIRFI
BIOGEN INC.
225 BINNEY ST.
CAMBRIDGE, MA 02142
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
RESTRICTED STOCK UNIT | 0.0 | 2021-02-18 | deemed execution date | A | 14,500 (a) | 2024-02-18 | common stock 14,500 | $0.00 | 14,500 | direct |
ID | footnote |
---|---|
f1 | the number of rsus reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. one-third of these rsus are eligible to vest on each of the first three anniversaries of the grant date. the actual number of shares that will vest on each vesting date will be determined by comparing the price of biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]). |